Whole body TXNIP deficiency and beta cell specific TXNIP deletion have been shown to protect mice against diabetes in models of T1D and T2D including streptozotocin (STZ)-induced beta cell destruction and genetic obesity and insulin resistance (14). This evidence concerns the gene TXNIP and type 1 diabetes mellitus.